Trump Administration Seeks to Influence NIH Grantmaking

The Trump administration is reportedly unhappy with how grants from the National Institutes of Health (NIH) are awarded. Discussions have begun to introduce more political control over the distribution of funds.

Meeting Details Senior staffers in the Oval Office debated whether NIH funds research opposing President Trump’s priorities. Reports indicate an executive order might establish an external committee to veto awards that conflict with Trump’s agenda.

White House Office of Management and Budget Director Russell Vought allegedly criticized NIH for supporting ‘woke’ projects. NIH Director Jay Bhattacharya defended the current grantmaking approach.

Official Response Emily Hilliard, senior press secretary at the Department of Health and Human Services (HHS), stated, “HHS remains focused on NIH’s core mission of supporting rigorous biomedical research that improves the health of the American people.”

Senate Reaction Senators Susan Collins and Patty Murray, leaders of the Senate Appropriations Committee, reacted strongly. Collins emphasized, “The Office of Management and Budget should not be involved in agency decisions on the awards of grants.” Murray added, “NIH funding doesn’t belong to Donald Trump – it belongs to the patients and families waiting on the next medical breakthrough.”

Healthcare Influences The article outlines policy impacts on healthcare, showcasing various statements and reactions to proposed changes in NIH funding and other healthcare-related news, including Illinois Governor JB Pritzker discussing weight loss with GLP-1 drugs.

Upcoming Events The Senate Health, Education, Labor, and Pensions Committee will hold meetings to review nominations for pivotal healthcare roles.